Introduction
============

Only 1--2% of human genome lies within protein-coding sequence ([@evu116-B16]). Determining the extent to which the remainder of the genome is functional is crucial to our understanding of human biology. A variety of recently developed experimental techniques have aided in the search of noncoding DNA for functional elements ([@evu116-B8]); however, on their own these techniques can produce a huge number of false positives ([@evu116-B11]). Searches for the evolutionary signature of purifying selection have therefore proved a more fruitful strategy for identifying functional elements; indeed phylogenetic searches comparing sequences of related species have revealed that approximately 5% of the human genome is constrained by natural selection ([@evu116-B4]; [@evu116-B26]; [@evu116-B17]; [@evu116-B2]; [@evu116-B6]), and similar strategies have been used to predict the phenotypic severity of mutations ([@evu116-B29]). Although whole-genome comparisons aimed at identifying the footprints of selection are highly effective, they have been used primarily to detect elements under constraint for hundreds of millions of years of evolutionary history ([@evu116-B26]; [@evu116-B6]). However, the set of functional elements in the genome experiences considerable turnover ([@evu116-B7]). Comparative genomic techniques will fail in these instances, particularly for the supremely interesting cases of human-specific gain ([@evu116-B15]) and loss of function ([@evu116-B30]).

Surveys of genetic diversity within species, on the other hand, have the potential to identify regions currently experiencing purifying selection and that are therefore functional, as purifying selection will remove genetic diversity from such loci. Unfortunately, genetic variation in the human genome is quite sparse, with a comparison of any two homologous chromosomes uncovering less than 1 single-nucleotide polymorphism (SNP) every kilobase ([@evu116-B16]). Sampling more individuals, however, yields additional polymorphisms, and an ultradeep sample of mitochondrial variation from 16,411 genomes is available in the MITOMAP database ([@evu116-B24]). These data are extremely polymorphic, with more than one SNP on every other base pair on average. This data set thus serves as an ideal proving ground for the approach of identifying functional constraint using massive amounts of polymorphism data, which will soon be available for nuclear genomes. Here, we show that the density of polymorphism in these data closely tracks divergence at a fine scale, implying that these data can indeed be used to reveal the strength of purifying selection in the human mitochondrial genome at a very high resolution. Our results suggest an enormous potential for population genomic data to uncover functional DNA elements, including those not conserved across species.

Results and Discussion
======================

We set out to determine the extent to which polymorphism data reveal the strength of purifying selection across the human mitochondrial genome and downloaded the coordinates of all 8,944 SNPs from MITOMAP (<http://www.mitomap.org/MITOMAP>, last accessed August 4, 2013). We reasoned that if the density of polymorphism was governed by the amount of purifying selection acting on each site, then SNP density would be correlated with divergence across species, in accordance with expectations under the Neutral model ([@evu116-B14]). This is indeed what we observe in the form of a strong correlation between the number of alleles per site and its average negated phyloP score ([@evu116-B25]) measuring divergence across vertebrates (Spearman's *ρ* = 0.52; *P* \< 2.2 × 10^−16^). This correlation is also highly significant when averaging polymorphism and divergence within 10-bp adjacent windows (*ρ* = 0.50; *P* \< 2.2 × 10^−16^; [fig. 1](#evu116-F1){ref-type="fig"}). F[ig]{.smallcaps}. 1.---The correlation between polymorphism and divergence in the human mitochondrial genome. The average number of alleles per base pair in 10-bp windows is shown in the *x*-axis and divergence as measured by the negated phyloP score is shown in the *y*-axis.

Although this observation is consistent with purifying selection both removing diversity and constraining divergence at functional elements, such a pattern could also be generated by variation in the spontaneous mutation rate. It has been shown that mutation rate in the mitochondria varies according to the duration for which a given site remains single stranded on the H strand (*D*~ssH~) during DNA replication ([@evu116-B23]). We also find evidence for this in the form of a significant correlation between divergence at each site and the duration the site is single stranded on the H strand during replication, although this correlation is far weaker than that shared between polymorphism and divergence (*ρ* = 0.11; *P* \< 2.2 × 10^−16^). Moreover, after correcting for *D*~ssH~, the correlation between polymorphism and divergence at individual sites is essentially unchanged and still highly significant (*ρ* = 0.49; *P* \< 2.2 × 10^−16^).

Rather than being driven by a subset of mitochondrial loci, this correlation is significant (at *P* \< 0.05) in 36/37 genes and is significant in 35/37 genes after correcting for *D*~ssH~ ([table 1](#evu116-T1){ref-type="table"}). Similarly, polymorphism and divergence are more strongly correlated in protein-coding (*ρ* = −0.53; *P* \< 2.2 × 10^−16^) and RNA-coding genes (*ρ* = −0.43; *P* \< 2.2 × 10^−16^) than noncoding DNA within the control region (*ρ* = −0.23; *P* = 9.3 × 10^−15^) or outside of it (*ρ* = −0.30; *P* = 0.021). This correlation is also far stronger at nonsynonymous than synonymous sites (*ρ* = 0.25 for second codon position sites, *P* \< 2.2 × 10^−16^; *ρ* = 0.079 for 4-fold degenerate sites, *P* = 3.6 × 10^−4^; [fig. 2](#evu116-F2){ref-type="fig"}) as expected if purifying selection is a more predominant force at nonsynonymous sites. Finally, the minor allele frequencies of SNPs from the Human Mitochondrial Genome Database (mtDB; [@evu116-B12]) are correlated with divergence (*ρ* = 0.076; *P* = 4.0 × 10^−16^), even though variation in mutation rate is not expect to affect allele frequencies. Thus, purifying selection uniquely drives patterns of polymorphism in the human mitochondrial genome. This finding supports previous reports that purifying selection is a prominent force in the mitochondrial genome ([@evu116-B22]; [@evu116-B19]; [@evu116-B10]; [@evu116-B28]). The patterns we observed are not the result of positive selection, as the fixation of a beneficial mutation through a selective sweep removes all genetic diversity from a nonrecombining chromosome ([@evu116-B27]). We are thus limited to observing mutations occurring since the most recent sweep. F[ig]{.smallcaps}. 2.---The correlation between polymorphism and divergence at nonsynonymous and synonymous sites. The number of alleles observed at each site is shown in the *x*-axis, and divergence (negative phyloP score) is shown in the *y*-axis at (*A*) second codon position (nonsynonymous) sites and (*B*) 4-fold degenerate (synonymous) sites. We added noise to the number of alleles to reveal the density of sites along the *y*-axis. Table 1Gene-Specific Correlations Between SNP Density and Negative phyloP ScoreGene NameGene DescriptionGene Start (hg19)Gene End (hg19)Spearman's *ρP*Spearman\'s *ρ* (Correcting for *D*~ssH~)*P*(Correcting for *D*~ssH~)*MT-TF*tRNA phenylalanine579649−0.4841.90 × 10^−5^−0.4689483.71 × 10^−5^*MT-RNR1*12S ribosomal RNA6501603−0.429\<2.20 × 10^−16^−0.4169046\<2.20 × 10^−16^*MT-TV*tRNA valine16041672−0.3360.004783−0.3260220.006261*MT-RNR2*16S ribosomal RNA16733230−0.443\<2.20 × 10^−16^−0.4435798\<2.20 × 10^−16^*MT-TL1*tRNA leucine 132313305−0.3010.008593−0.298370.00932*MT-ND1*NADH dehydrogenase subunit 133084263−0.542\<2.20 × 10^−16^−0.5149936\<2.20 × 10^−16^*MT-TI*tRNA isoleucine42644332−0.2690.02551−0.25237450.03643*MT-TQ*tRNA glutamine43304401−0.4634.19 × 10^−5^−0.4763852.34 × 10^−5^*MT-TM*tRNA methionine44034470−0.2910.01611−0.28807270.01721*MT-ND2*NADH dehydrogenase subunit 244715512−0.516\<2.20 × 10^−16^−0.461188\<2.20 × 10^−16^*MT-TW*tRNA tryptophan55135580−0.5099.42E × 10^−6^−0.46268127.11 × 10^−5^*MT-TA*tRNA alanine55885656−0.4290.0002381−0.44126210.0001475*MT-TN*tRNA asparagine56585730−0.3780.0009899−0.37656260.001025*MT-TC*tRNA cysteine57625827−0.5961.26 × 10^−7^−0.57098375.55 × 10^−7^*MT-TY*tRNA tyrosine58275892−0.3520.00371−0.34865350.004118*MT-CO1*Cytochrome *c* oxidase subunit I59057446−0.633\<2.20 × 10^−16^−0.6186776\<2.20 × 10^−16^*MT-TS1*tRNA serine 174477515−0.6278.31 × 10^−9^−0.61072292.51 × 10^−8^*MT-TD*tRNA aspartic acid75197586−0.3650.002186−0.3202530.007758*MT-CO2*Cytochrome *c* oxidase subunit II75878270−0.573\<2.20 × 10^−16^−0.5291891\<2.20 × 10^−16^*MT-TK*tRNA lysine82968365−0.3310.005158−0.28099190.01846*MT-ATP8*ATP synthase F0 subunit 883678573−0.2660.0001042−0.26372310.0001233*MT-ATP6*ATP synthase F0 subunit 685289208−0.389\<2.20 × 10^−16^−0.3823366\<2.20 × 10^−16^*MT-CO3*Cytochrome *c* oxidase subunit III92089991−0.538\<2.20 × 10^−16^−0.5314281\<2.20 × 10^−16^*MT-TG*tRNA glycine999210059−0.3960.0008191−0.34048120.004497*MT-ND3*NADH dehydrogenase subunit 31006010405−0.510\<2.20 × 10^−16^−0.5000739\<2.20 × 10^−16^*MT-TR*tRNA arginine1040610470−0.4707.66 × 10^−5^−0.44152060.0002317*MT-ND4L*NADH dehydrogenase subunit 4L1047110767−0.491\<2.20 × 10^−16^−0.5133884\<2.20 × 10^−16^*MT-ND4*NADH dehydrogenase subunit 41076112138−0.561\<2.20 × 10^−16^−0.5419698\<2.20 × 10^−16^*MT-TH*tRNA histidine1213912207−0.2770.02112−0.17864130.1419*MT-TS2*tRNA serine 21220812266−0.4700.0001712−0.4891468.45 × 10^−5^*MT-TL2*tRNA leucine 21226712337−0.3740.001311−0.35430690.002434*MT-ND5*NADH dehydrogenase subunit 51233814149−0.532\<2.20 × 10^−16^−0.5141183\<2.20 × 10^−16^*MT-ND6*NADH dehydrogenase subunit 61415014674−0.500\<2.20 × 10^−16^−0.4776221\<2.20 × 10^−16^*MT-TE*tRNA glutamic acid1467514743−0.3470.003468−0.34767310.003421*MT-CYB*Cytochrome *b*1474815888−0.551\<2.20 × 10^−16^−0.5025513\<2.20 × 10^−16^*MT-TT*tRNA threonine1588915954−0.5601.00 × 10^−6^−0.43547230.0002578*MT-TP*tRNA proline1595716024−0.1030.4044−0.18702940.1267

Having established that patterns of polymorphism across the human mitochondria are largely determined by purifying selection, we sought to determine the resolution at which these data reveal the strength of selection acting on particular sites in the genome. We examined patterns of SNP diversity and divergence in 5-bp sliding windows across each gene in the mitochondrial genome, observing the extent to which the two measures mirror one another on a small scale. In particular, within each window, we calculated the average SNP density per base pair and the average probability that the site is not conserved across vertebrates according to phastCons ([@evu116-B26]). We find that for many loci, tRNA genes in particular, these two measures track one another to a surprising extent (e.g., the phenylalanine and tryptophan tRNA genes shown in [fig. 3](#evu116-F3){ref-type="fig"}; the remaining tRNA genes are shown in [supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu116/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu116/-/DC1) online). This result demonstrates that SNP density has the ability to reveal the strength of selection at a surprisingly detailed resolution---on the scale of a few base pairs. F[ig]{.smallcaps}. 3.---The probability of polymorphism versus the probability of unconstrained evolution across vertebrates. (*A*) The 5-bp sliding genomic windows showing SNP density (blue) and one minus the probability of conservation across vertebrates (red) according to phastCons ([@evu116-B26]) across the phenylalanine tRNA gene. (*B*) The same plot for the tryptophan tRNA gene.

As a simple proof of concept, we sought to use SNP density to predict function at a fine scale via a hidden Markov model (HMM; [@evu116-B21]). Using a similar strategy as phastCons ([@evu116-B26]), we learned a two-state HMM (constrained vs. unconstrained) where the observation for each site in the genome is the number of alleles at the site. We then used this HMM to predict constrained regions to which we refer as mitoPopCons elements. There is extremely strong overlap between mitoPopCons elements obtained from polymorphism data and phastCons elements predicted from divergence (*P* \< 0.0001; [fig. 4](#evu116-F4){ref-type="fig"}; see Materials and Methods). Although mitoPopCons recovers somewhat fewer genic base pairs than phastCons (35.4% of all genic base pairs are recovered by mitoPopCons versus 49.7% by phastCons), mitoPopCons elements contain fewer intergenic base pairs (0.75% of mitoPopCons base pairs are intergenic versus 3.4% of phastCons bases). Given the dramatically deeper evolutionary time period examined by phastCons data, that it seems to perform only marginally better than mitoPopCons underscores the potential of population genetic approaches. phastCons elements are smaller and more numerous (1,395 elements averaging 6.7 bp in length) than mitoPopCons elements (33 elements averaging 167 bp), perhaps implying that phylogenetic data allow for higher resolution prediction than even our dense polymorphism data. On the other hand, element length distributions may have been influenced by the difference in emission probability training methods used for mitoPopCons (trained via the Baum--Welch algorithm; see Materials and Methods) and phastCons elements. In any case, the success of this simple HMM shows that SNP diversity has the ability to accurately predict function at a fine scale in the human mitochondria. F[ig]{.smallcaps}. 4.---Comparison of conserved elements called from phylogenetic data and those called from population genetic data. This image form the UCSC Genome Browser shows positions 1--5,000 of the human mitochondrial genome. Conserved elements called from the polymorphism-based HMM (mitoPopCons) appear in blue, whereas phastCons elements obtained from a comparison of mammalian genomes appear in red. phastCons conservation probabilities are shown at the bottom in green. Gene locations are shown at the top.

We have shown that ultradense polymorphism data can be used to accurately detect functional nucleotides in the human mitochondrial genome, potentially at the level of the individual base pair, while sidestepping limitations of phylogenetic approaches. This result suggests that as whole-genome sequencing becomes more ubiquitous, it may become possible to perform such high-resolution prediction in the nuclear genome as well. Applying a polymorphism-based approach to the nuclear genome will present several additional challenges. First, independent assortment and recombination in the nuclear genome cause different loci to have distinct genealogical histories and therefore varying levels of diversity under neutrality, thereby potentially impeding the detection of selection. As another consequence of recombination, both positive ([@evu116-B27]) and negative selection ([@evu116-B3]) will have localized effects on flanking variation, rather than genome wide as in the mitochondria. These forces will further increase variance in polymorphism at unselected sites and may thus obscure the signal of negative selection at selected sites.

Another difficulty of the nuclear genome is that its nucleotide diversity is far lower than that of the mitochondrial genome ([@evu116-B16]), meaning that an even larger number of sequences than examined here may be required to accurately detect selection. Moreover, the power to detect function increases logarithmically with sample size ([supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu116/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu116/-/DC1) online). However, given the ever-increasing rate at which new human genome sequences are released, this problem may not be insurmountable. Finally, there is likely more variation in the strength of purifying selection acting in the nuclear genome than in the mitochondria. As a consequence, weakly constrained but still functionally important regions may evade detection, especially by a two-state method, allowing for only one level of constraint like the HMM used here.

If these hurdles can be overcome, approaches such as ours will then have an enormous impact on biological research, allowing for the discovery of the complete set of functional elements in the human genome and the degree to which new mutations at each site are deleterious. Such efforts will vastly improve predictions of the phenotypic impact of mutations occurring in humans and will prioritize searches for disease-causing mutations. This information will also reveal species-specific changes in selective pressures at the resolution of individual nucleotides, thereby greatly improving our understanding of how the functional components of genomes evolve.

Materials and Methods
=====================

We converted all coordinates obtained from MITOMAP and mtDB from the Cambridge Reference Sequence (CRS) coordinate space to the human reference genome's (GRCh37) coordinate space by aligning the two mitochondrial sequences using MUSCLE ([@evu116-B9]). We downloaded phyloP scores for each mitochondrial site from the UCSC Genome Browser Database ([@evu116-B18]). Because there are no allele frequency data available for MITOMAP SNPs, we used the number of alleles at each site as our measure of diversity. For the correlation of minor allele frequency with divergence, we used frequencies of biallelic SNPs from mtDB. We measured the duration of single strandedness (*D*~ssH~) following [@evu116-B5], using the coordinates of the light-strand origin of replication from MITOMAP. For the *D*~ssH~ analyses, we omitted sites within the control region. To control for the *D*~ssH~-divergence correlation, we fit a generalized linear model treating the number of segregating alleles at each site as a Poisson distributed response variable and with *D*~ssH~ value as the predictive variable using R. We then calculated the correlation between phyloP scores and the polymorphism residuals.

The HMM analysis was performed in MATLAB with the same transition matrix as used to learn the phastCons HMM for the UCSC Genome Browser ([@evu116-B13]). For each base pair, the emitted observation was the number of alleles (ranging one and four) found in the MITOMAP data set. The rationale for this approach was that after training the HMM, its two states should have different probabilities of emitting 1, 2, 3, or 4 alleles at a given site, and this would result in one state being more likely in stretches of DNA under selective constraint, whereas the other state would have higher likelihood in less constrained sequences. After assigning an initially random emission probability matrix, we then used Baum--Welch training to learn the emission parameters only for the constrained and unconstrained states by using large number of pseudocounts for transition matrix to ensure that it remained invariant during training. To guard against convergence at a poor local optimum, we repeated this process ten times and kept the emission matrix under which the observed sequence data had the highest likelihood. After training, we considered the state with the higher probability of emitting monomorphic sites to be the "functional" state and the other state to be "nonfunctional." Next, we predicted constrained elements by using the Viterbi algorithm. We tested for significant overlap between our HMM predictions and mammalian phastCons elements from the UCSU Genome Browser by counting the number of base pairs constrained according to both methods and compared this count with those obtained after permuting the coordinates of our predictions. This was repeated for 10,000 permutations to obtain a *P* value.

To reveal the relationship between sample size and the HMM's power to recover functional sites, we also repeated the HMM analysis as described above for different sample sizes using the number of alleles at each site in the mtDB set---the MITOMAP set could not be used for this as it lacks reliable allele frequency estimates. The sample sizes we examined ranged from 100 to 1,800, incrementing by 100. We also used a sample size of 1,864, which was the minimum sample size among all SNPs in the mtDB set. For each sample size, we randomly downsampled from the full mtDB data set by randomly drawing the desired number of alleles from the full set at each site without replacement. We then counted the number of distinct alleles observed at each site within the downsampled set, and this number was used as the observation for the HMM.

Supplementary Material
======================

[Supplementary figures S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu116/-/DC1) and [S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu116/-/DC1) are available at *Genome Biology and Evolution* online (<http://www.gbe.oxfordjournals.org/>).

###### Supplementary Data

This work was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award F32 GM105231-01 to D.R.S. and in part by Rutgers University and National Science Foundation Award MCB-1161367 to A.D.K.

[^1]: **Associate editor:** Dan Graur
